News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
637,969 Results
Type
Article (52573)
Company Profile (176)
Press Release (585220)
Multimedia
Podcasts (77)
Webinars (9)
Section
Business (179326)
Career Advice (2718)
Deals (33042)
Drug Delivery (113)
Drug Development (78932)
Employer Resources (166)
FDA (16467)
Job Trends (15223)
News (316606)
Policy (32350)
Tag
Academia (2842)
Accelerated approval (6)
Adcomms (28)
Allergies (92)
Alliances (46411)
ALS (94)
Alzheimer's disease (1434)
Antibody-drug conjugate (ADC) (145)
Approvals (16430)
Artificial intelligence (279)
Autoimmune disease (28)
Automation (16)
Bankruptcy (341)
Best Places to Work (11573)
BIOSECURE Act (19)
Biosimilars (118)
Biotechnology (122)
Bladder cancer (83)
Brain cancer (31)
Breast cancer (296)
Cancer (2344)
Cardiovascular disease (199)
Career advice (2291)
Career pathing (33)
CAR-T (166)
Cell therapy (453)
Cervical cancer (19)
Clinical research (64461)
Collaboration (877)
Company closure (1)
Compensation (255)
Complete response letters (30)
COVID-19 (2829)
CRISPR (45)
C-suite (250)
Cystic fibrosis (107)
Data (2216)
Decentralized trials (2)
Denatured (19)
Depression (54)
Diabetes (287)
Diagnostics (6429)
Digital health (19)
Diversity (3)
Diversity, equity & inclusion (38)
Drug discovery (123)
Drug pricing (114)
Drug shortages (29)
Duchenne muscular dystrophy (100)
Earnings (67222)
Editorial (45)
Employer branding (22)
Employer resources (146)
Events (85990)
Executive appointments (751)
FDA (17762)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (761)
Gene editing (113)
Generative AI (25)
Gene therapy (334)
GLP-1 (817)
Government (4740)
Grass and pollen (6)
Guidances (75)
Healthcare (18744)
Huntington's disease (26)
IgA nephropathy (30)
Immunology and inflammation (141)
Indications (29)
Infectious disease (2986)
Inflammatory bowel disease (140)
Inflation Reduction Act (8)
Influenza (55)
Intellectual property (100)
Interviews (509)
IPO (14720)
IRA (42)
Job creations (4033)
Job search strategy (1911)
Kidney cancer (11)
Labor market (32)
Layoffs (535)
Leadership (24)
Legal (7347)
Liver cancer (82)
Lung cancer (333)
Lymphoma (155)
Machine learning (7)
Management (59)
Manufacturing (316)
MASH (70)
Medical device (13274)
Medtech (13279)
Mergers & acquisitions (18816)
Metabolic disorders (757)
Multiple sclerosis (85)
NASH (21)
Neurodegenerative disease (111)
Neuropsychiatric disorders (31)
Neuroscience (2013)
NextGen: Class of 2025 (6761)
Non-profit (4852)
Now hiring (32)
Obesity (410)
Opinion (246)
Ovarian cancer (77)
Pain (95)
Pancreatic cancer (84)
Parkinson's disease (155)
Partnered (20)
Patents (224)
Patient recruitment (111)
Peanut (50)
People (54389)
Pharmaceutical (31)
Pharmacy benefit managers (20)
Phase I (20038)
Phase II (28156)
Phase III (21591)
Pipeline (1238)
Policy (158)
Postmarket research (2562)
Preclinical (7816)
Press Release (63)
Prostate cancer (109)
Psychedelics (34)
Radiopharmaceuticals (231)
Rare diseases (407)
Real estate (5691)
Recruiting (69)
Regulatory (22473)
Reports (35)
Research institute (2508)
Resumes & cover letters (414)
Rett syndrome (5)
RNA editing (4)
RSV (50)
Schizophrenia (78)
Series A (137)
Series B (88)
Service/supplier (9)
Sickle cell disease (56)
Special edition (16)
Spinal muscular atrophy (156)
Sponsored (26)
Startups (3566)
State (1)
Stomach cancer (15)
Supply chain (72)
Tariffs (44)
The Weekly (56)
Vaccines (800)
Venture capitalists (43)
Weight loss (285)
Women's health (31)
Worklife (20)
Date
Today (142)
Last 7 days (773)
Last 30 days (2443)
Last 365 days (30810)
2025 (10255)
2024 (33073)
2023 (37837)
2022 (48493)
2021 (52902)
2020 (52608)
2019 (46512)
2018 (35736)
2017 (32329)
2016 (31338)
2015 (35415)
2014 (27071)
2013 (22252)
2012 (23986)
2011 (24759)
2010 (22068)
Location
Africa (927)
Alabama (55)
Alaska (7)
Arizona (174)
Arkansas (14)
Asia (37972)
Australia (6552)
California (5904)
Canada (1744)
China (504)
Colorado (262)
Connecticut (259)
Delaware (119)
Europe (87358)
Florida (814)
Georgia (188)
Hawaii (1)
Idaho (59)
Illinois (525)
India (26)
Indiana (302)
Iowa (9)
Japan (156)
Kansas (96)
Kentucky (26)
Louisiana (11)
Maine (68)
Maryland (836)
Massachusetts (3871)
Michigan (214)
Minnesota (356)
Mississippi (2)
Missouri (84)
Montana (26)
Nebraska (25)
Nevada (56)
New Hampshire (69)
New Jersey (1545)
New Mexico (30)
New York (1618)
North Carolina (923)
North Dakota (9)
Northern California (2520)
Ohio (188)
Oklahoma (13)
Oregon (34)
Pennsylvania (1195)
Puerto Rico (12)
Rhode Island (30)
South America (1283)
South Carolina (21)
South Dakota (1)
Southern California (2280)
Tennessee (98)
Texas (806)
United States (21238)
Utah (193)
Virginia (143)
Washington D.C. (62)
Washington State (523)
West Virginia (3)
Wisconsin (52)
637,969 Results for "limflow sa".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Deals
Inari Medical Closes Acquisition of LimFlow
Inari Medical, Inc. announced the close of its acquisition of LimFlow S.A., a privately-held pioneer in limb salvage for patients with chronic limb-threatening ischemia.
November 15, 2023
·
3 min read
Deals
LimFlow Announces Agreement to Be Acquired by Inari Medical
LimFlow SA announced that it has entered into a definitive agreement to be acquired by Inari Medical, a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases.
November 1, 2023
·
3 min read
Deals
Inari Medical Expands Its Patient-Focused Mission with Agreement to Acquire LimFlow
Inari Medical, Inc. announced that it has entered into a definitive agreement to acquire LimFlow, S.A., a privately held pioneer in limb salvage for patients with chronic limb-threatening ischemia.
November 1, 2023
·
9 min read
FDA
FDA Approves LimFlow System in Patients With Chronic Limb-Threatening Ischemia and No Suitable Endovascular or Surgical Revascularization Options
LimFlow SA announced today that the U.S. Food and Drug Administration (FDA) has approved the LimFlow System to help people with CLTI who have no other suitable endovascular or surgical treatment options and are facing major amputation.
September 12, 2023
·
5 min read
Press Releases
Ipsen S.A. - Formalities for making available and consulting preparatory documents to the 2025 Annual General Meeting
May 1, 2025
·
6 min read
Landmark New England Journal of Medicine Publication Reports Positive Results From PROMISE II Pivotal Trial Showing that LimFlow System Saves Most Patients with End-stage Peripheral Artery Disease From Major Amputation
LimFlow SA announced that results from the PROMISE II U.S. pivotal trial were published.
March 30, 2023
·
6 min read
Business
LimFlow Appoints Jenny Gaffney as Vice President, Health Economics and Reimbursement
LimFlow SA today announced the appointment of Jenny Gaffney as Vice President, Health Economics and Reimbursement.
August 23, 2022
·
3 min read
Press Releases
LimmaTech Vaccinates First Participants in Phase 1 Study of Staphylococcus aureus Vaccine Candidate LBT-SA7
February 17, 2025
·
4 min read
RELIEF THERAPEUTICS Holding SA Announces Results of Annual General Meeting
RELIEF THERAPEUTICS Holding SA announces the results of its annual general meeting (AGM) of shareholders, which took place in Geneva today.
June 27, 2024
·
3 min read
LimFlow Raises $40 Million (€36 Million) in Series D Financing
LimFlow SA today announced it has closed a $40 million (€36 million) oversubscribed Series D financing round.
April 5, 2022
·
4 min read
1 of 63,797
Next
